date,title,source
Oct-31-18,Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM,GlobeNewswire
Nov-01-18,"Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018",GlobeNewswire
